The content discusses Abiomed's recall of the instructions for use (IFU) for its Impella left-sided blood pumps due to potential risks associated with the pump catheter perforating the left ventricle wall. The recall, classified as Class I by the FDA, highlights the serious health consequences that may arise from the use of affected pumps, including injuries and deaths. The recall covers various Impella models distributed within a specific timeframe and provides guidelines for healthcare professionals to mitigate risks. Abiomed had previously recalled these pumps in the US due to safety concerns related to transcatheter aortic valve replacement (TAVR) stents.
In eine andere Sprache
aus dem Quellinhalt
www.medscape.com
Wichtige Erkenntnisse aus
by Megan Brooks um www.medscape.com 03-21-2024
https://www.medscape.com/viewarticle/another-class-i-recall-abiomed-impella-left-sided-blood-2024a10005bjTiefere Fragen